RxDoctor Payments Data

Michael Haney, PA

Surgical · West Columbia, SCNPI 1982338190

Payments from drug & device makers

$995in general payments, 2019–2025

Across 56 payments — averaging $17.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$267
  • Novartis$188
  • Novo Nordisk$136
  • Lilly USA, LLC$108
  • Pfizer$83
  • Dexcom, Inc.$68
  • plus $144 from 7 others

What the payments were for

  • Food & beverage$995100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$995 in reported general payments places this provider in the 60th percentile of 232 surgical providers in South Carolina.

See all surgical providers in South Carolina

Medicare billing

Part B allowed, 2024
$588
Medicare patients
34
Services billed
67

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide64$104,478
JardianceEmpagliflozin56$67,279
TrulicityDulaglutide33$49,611
FarxigaDapagliflozin Propanediol29$43,433
JanuviaSitagliptin Phosphate38$41,992
Breztri AerosphereBudesonide/Glycopyr/Formoterol20$34,225
Spiriva RespimatTiotropium Bromide23$19,706
TradjentaLinagliptin27$17,947
Tresiba Flextouch U-200Insulin Degludec21$16,029
Janumet XrSitagliptin Phos/Metformin Hcl12$14,838
SymbicortBudesonide/Formoterol Fumarate22$10,887
EliquisApixaban22$10,842
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog28$9,350
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr14$7,630
Lantus SolostarInsulin Glargine,hum.Rec.Anlog58$7,480

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$136$104,47864 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$267$88,54471 claims
MerckJanuvia, Janumet Xr$15$56,83050 claims
Lilly USA, LLCTrulicity$108$49,61133 claims
PfizerEliquis$83$10,84222 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 232 surgical providers in South Carolina.

Other surgical in West Columbia

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →